GO
Loading...

Pfizer, J&J Halt Alzheimer's Drug Trials

Tuesday, 7 Aug 2012 | 10:12 AM ET

CNBC's Seema Mody reports Pfizer and Johnson & Johnson are scrapping their phase three studies of Alzheimer's drug known as "Bapi" after it failed to slow memory loss.